Natriumtiosulfat Hope (Sodium Thiosulfate)

Sodium Thiosulfate, the active ingredient in Natriumtiosulfat Hope, is an antidote presented as a solution for injection for intravenous use. It treats cyanide poisoning and is also employed in specific calcium‑related conditions such as calciphylaxis and certain off‑label uses.

GNH USA supplies Natriumtiosulfat Hope as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Sodium Thiosulfate is used in emergency and specialty care to neutralize toxic agents and manage calcium‑related disorders. - Cyanide poisoning: rapidly converts cyanide to the less toxic thiocyanate, reducing systemic toxicity. - Calciphylaxis: assists in reducing calcium deposition in skin and vessels, aiding wound healing. - Radiation‑induced oral mucositis (off‑label): may alleviate mucosal injury and promote recovery.

Sodium Thiosulfate may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea - Vomiting - Hypotension - Flushing - Headache - Mild fever

Serious or Rare Side Effects: - Anaphylaxis - Severe hypotension - Metabolic acidosis - Renal impairment - Hemolysis - Electrolyte disturbances

When using Sodium Thiosulfate, clinicians should observe several safety measures. - Renal function: monitor because the drug is renally cleared. - Calcium levels: watch for hypocalcemia due to calcium chelation. - Blood pressure: observe for hypotensive episodes during infusion. - Pregnancy: safety unknown; use only if potential benefit outweighs risk. - Hypersensitivity: avoid in patients with known allergy to the product. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Sodium Thiosulfate can interact with other medicines; some require avoidance while others need close monitoring.

Major Interactions (Avoid): - Loop diuretics: may increase risk of hypocalcemia. - Calcium supplements: can reduce antidotal efficacy. - Nitroglycerin: additive hypotensive effect.

Moderate Interactions (Monitor Closely): - Anticoagulants: may alter bleeding risk. - ACE inhibitors: monitor blood pressure. - Beta‑blockers: observe for bradycardia.